Presenting symptoms of COVID‐19 and clinical outcomes in hospitalised older adults

Abstract

Background In July 2020, a COVID‐19 outbreak was recognised in the geriatric wards at a subacute campus of the Royal Melbourne Hospital affecting patients and staff. Patients were also admitted to this site after diagnosis in residential care. Aims To describe the early symptoms and the outcomes of COVID‐19 in older adults. Methods Patients diagnosed with COVID‐19 at the facility in July or August 2020 were identified and their medical records were examined to identify symptoms present before and after their diagnosis and to determine their outcomes. Results Overall, 106 patients were identified as having COVID‐19, with median age of 84.3 years (range 41–104 years); 64 were diagnosed as hospital inpatients after a median length of stay of 49 days, 31 were transferred from residential aged care facilities with a known diagnosis and 11 were diagnosed after discharge. There were 95 patients included in an analysis of symptom type and timing onset. Overall, 61 (64.2%) were asymptomatic at the time of diagnosis of COVID‐19, having been diagnosed through screening initiated on site. Of these, 88.6% developed symptoms of COVID‐19 within 14 days. The most common initial symptom type was respiratory, but there was wide variation in presentation, including fever, gastrointestinal and neurological symptoms, many initially not recognised as being due to COVID‐19. Of 104 patients, 32 died within 30 days of diagnosis. Conclusions COVID‐19 diagnosis is challenging due to the variance in symptoms. In the context of an outbreak, asymptomatic screening can identify affected patients early in the disease course.

Attitudes toward COVID-19 vaccination and willingness to pay: comparison of people with and without mental disorders in China

“…1 Although some people infected with COVID-19 remain asymptomatic, most patients present with fever and respiratory (sore throat, cough, nasal congestion, anosmia), gastrointestinal (nausea, vomiting) or neurological symptoms (headache), as well as myalgia and malaise. 2 Reported long-term effects of COVID-19 infection include attention deficit, dyspnoea, fatigue, hair loss and headache. 3 The fatality rate for COVID-19 is 1.4%.…”

Diabetes IN hospital – Glucose and Outcomes in the COVID‐19 pandemic (DINGO COVID‐19): the 2020 Melbourne hospital experience prior to novel variants and vaccinations

“…With the emergence in 2021 of new variants, such as B.1.1.529 (Omicron), where existing vaccines have reduced effectiveness in preventing infection, 2 the pre‐vaccination experience remains relevant, particularly as there are relatively few documented Australian COVID‐19 inpatient experiences to date. 3 , 4 , 5 , 6 …”

Advocacy for COVID‐19 vaccination at perioperative consultations: an opportunity for protection

“…The risk of infection varies depending on the local incidence of community infection, and the testing and infection control practices of healthcare institutions. Worldwide, nosocomial transmission has occurred, 3 , 4 although universal mask wearing by staff and patients may have reduced this risk. 5 Nosocomial SARS‐CoV‐2 infection has occurred in ENT, 6 general and orthopaedic surgery, 7 , 8 and is associated with a high post‐operative mortality risk.…”